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Abstract 
Purpose: There is growing interest about biological effective 
dose (BED) and its application in treatment plan evaluation 
due to its stronger correlation with treatment outcome. An 
approximate biological effective dose (BEDA) equation was 
introduced in order to simplify BED calculations by treat-
ment planning systems in multi-phase treatments. The pur-
pose of this work is to reveal its mathematical properties 
relative to the true, multi-phase BED (BEDT) equation. 
 
Methods: The BEDT equation was derived and used to reveal 
the mathematical properties of BEDA. MATLAB 
(MathWorks, Natick, MA) was used to simulate and analyze 
common and extreme clinical multi-phase cases. In those 
cases, percent error and Bland-Altman analysis were used to 
study the significance of the inaccuracies of BEDA for differ-
ent combinations of total doses, numbers of fractions, doses 
per fractions and α/β values. All the calculations were per-
formed on a voxel-basis in order to study how dose distribu-
tions would affect the accuracy of BEDA.  
 
Results: When the voxel dose-per-fractions (DPF) delivered 
by both phases are equal, BEDA and BEDT are equal (0% er-
ror). In heterogeneous dose distributions, which significantly 
vary between the phases, there are fewer occurrences of 
equal DPFs and hence the imprecision of BEDA is greater. It 
was shown that as the α/β ratio increased the accuracy of 
BEDA would improve. Examining twenty-four cases, it was 
shown that the range of DPF ratios for 3% Perror varied from 
0.32 to 7.50Gy, whereas for Perror of 1% the range varied from 
0.50 to 2.96Gy. 
 
Conclusion: The DPF between the different phases should be 
equal in order to render BEDA accurate. OARs typically re-
ceive heterogeneous dose distributions hence the probability 
of equal DPFs is low. Consequently, the BEDA equation 
should only be used for targets or OARs that receive uniform 
or very similar dose distributions by the different treatment 
phases. 
------------------------------------------------------------------- 
Impact: To our knowledge, it is a usual practice to 
use BEDA instead of BEDT due to its convenience with 
current treatment planning systems (TPS). This was 
shown to be a potential problem with our mathemat-
ical analysis of BEDA. The goal of this work was to 
quantitatively measure the accuracy of BEDA under 
many different circumstances, and also reveal its po-
tential imprecision in clinical circumstances regarding 
healthy organs. This work puts emphasis on the im-
portance of creating future TPS with the capability of 
calculating the BEDT. 
 
Key Results: Using the multi-phase equations of 
BEDT and BEDA, specifically two-phases (e.g., pri-
mary and boost), the percent error (Perror) equation 
was derived. Five variables within this equation are 
the α/β ratio, which is a tissue-dependent constant of 
the linear-quadratic (LQ) cell- survival curve model, 
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the dose-per-fractions (DPF) for both phases, and the 
number of fractions for both phases. The Perror equa-
tion reveals the many varying factors in the accuracy 
of BEDA. Figure 1 displays the change of Perror with 
respect to four of the variables, except α/β, which is 
instead shown in Figure 2. As seen, the main deter-
mining factor in the accuracy of BEDA is the 
DPF-ratio, which, when it gets equal to 1, Perror be-
comes equal to 0% (see Figure 1). Since DPF- ratio is 
the most important factor in the accuracy of BEDA, 
and due to its dependence upon the dose distribution, 
we have shown that using BEDA on OARs could po-
tentially lead to significant errors. On the other hand, 
its application to target volumes would instead pro-
duce less error due to fact that target volumes typical-







FIG. 1: As seen in all three plots, as the DPF-ratio steers from 1, Perror increases. Also, as npri/nbst increases, Perror decreases. The DPF-ratiomax 





FIG. 2: (a) This is a plot with DPF-ratios > 1, while (b) is with DPF-ratios < 1. When dpri/dbst is less than one, notice the steeper drop in Perror 
with a change in DPF. 
 
 
 
